Stay updated on ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial

Sign up to get notified when there's something new on the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now presents the completed Phase 3 study record comparing ABP 215 with bevacizumab for advanced non-small cell lung cancer, including study methods, participant criteria, locations, and reported outcomes.
    Difference
    55%
    Check dated 2026-11-09T00:21:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T00:09:25.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide NIH notice appears above the page, linking to transition updates and saying NIH content may use “Super Intelligence” alongside “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T23:54:31.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T00:33:19.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T00:26:57.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study content, accompanied by an HTML skeleton and a Home button; the footer notes a site Revision: v3.7.0. This indicates an access restriction or server issue preventing viewing the study details.
    Difference
    19%
    Check dated 2026-09-20T22:56:31.000Z thumbnail image

Stay in the know with updates to ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 215 vs Bevacizumab in Advanced NSCLC Clinical Trial page.